NCEL:NASDAQ, NewcelX Ltd.

NCEL stock overview

NewcelX Ltd. (NCEL:NASDAQ) closed at $2.54 on November 20, 2026, down 5.58% on the day. The stock trades 50.4% below its 52-week high of $5.12 and 38.8% above its 52-week low of $1.83. Over the past year, it lost 24.2%. NewcelX Ltd. is part of the Health Care sector.

Key figures

Price
$2.54
Day change
-5.58%
Volume
5,608
Average volume
13,273
Market cap
14M+
52-week range
$1.83 – $5.12
50-day average
$2.85
200-day average
$3.11

Price action over the past year

In 252 trading sessions since November 20, 2025, NCEL closed higher on 108 days (43%). Its best day was April 23, 2026 (+34.15%) and its worst was December 11, 2025 (-21.83%). The stock moved 10% or more in a single session 25 times. It opened at least 5% above the previous day's high 5 times.

Recent signals

NCEL news

About NewcelX Ltd.

At NewcelX, we leverage our combined strengths in advanced cell therapy solutions and innovative approaches in metabolic interventions to treat complex medical needs, positioning ourselves for unprecedented growth in the biotechnology sector. Our expertise enables us to address multifaceted conditions such as amyotrophic lateral sclerosis (ALS), other neurodegenerative diseases and insulin-dependent diabetes, ensuring we deliver comprehensive, patient-centered solutions.Driving scientific innovation is at the heart of NewcelX. By pooling our research and development efforts, we accelerate breakthroughs in the science. This focus enhances the quality of our product offerings while expediting the development process, for unmet medical needs.As we continue to grow, NewcelX is dedicated to creating synergistic therapies that promise a broader impact on patients' lives.

Similar stocks

Find more stocks like NCEL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.